11 July 2025 in Kidney360
An abstract is unavailable. This article is available as a PDF only.
18 June 2025 in American Journal of Transplantation
Older (aged ≥55 years) kidney transplant (KT) recipients diagnosed with a sleep disorder after transplantation may be at increased risk for developing dementia. Using the United States Renal Data System/Medicare claims (2010-2020), we identified 16 573 older KT recipients with a functioning graft 1-year post-KT. First-time sleep disorders and newly prescribed sleep medications were ascertained within the first year post-KT. We used cause-specific hazard models to estimate the adjusted hazard ratio of diagnosed dementia with inverse probability of treatment weights. Overall, 3615 (21.8%) KT recipients were newly diagnosed with sleep disorders. Recipients diagnosed with a sleep disorder had a 1.32-fold increased risk for dementia (95% CI:1.15-1.51); those with insomnia had a 1.56-fold increased risk (95% CI:1.20-2.03). Of those diagnosed with insomnia, only 7.5% underwent cognitive behavioral therapy for insomnia. Of the recipients, 12.9% with a sleep disorder were prescribed sleep medications. Recipients prescribed sleep medication had a 1.44-fold increased risk for dementia (95% CI:1.16-1.77). Those prescribed zolpidem, the most commonly prescribed medication (80.1%), had a 1.41-fold increased risk (95% CI:1.12-1.78) for dementia; those prescribed other sleep medications had 3.13-fold (95% CI:1.41-6.98) increased risk for dementia. Post-KT sleep disorders are modifiable dementia risk factors; medication-associated dementia risk should be weighed against other therapies such as cognitive behavioral therapy for insomnia during management.
7 January 2026 in Journal of the American Geriatrics Society
19 October 2026 in Journal of the American Geriatrics Society
KCKidney Disease Aging Research Collaborative
Kidney Disease Aging Research Collaborative
+8
15 October 2025 in The Lancet Regional Health - Americas
Racial/ethnic dementia disparities among older adults with end-stage kidney disease (ESKD) are likely driven by environmental and social injustices. We quantified the impact of fine particulate air pollution exposure (PM2.5; environmental injustice) by racial/ethnic segregation (social injustice) on dementia diagnosis in ESKD. We leveraged the US national registry to identify 884 950 older adults (age ≥55 years) who initiated dialysis (2003–2019). Adjusted Cox regression models with shared state-level frailty quantified the adjusted hazard ratio (aHR) of dementia by PM2.5 concentrations (annualized and matched to older adults' residential ZIP code at dialysis initiation) and by segregation scores (Theil's H method). Older ESKD adults residing in neighborhoods with high PM2.5 (n = 598,778, 59,515 with dementia) experienced a 1.44-fold (95% confidence interval (CI):1.41–1.47) higher risk of dementia; this association differed by race and ethnicity (Pinteraction<0.0001). Dementia risk was exacerbated for those residing in neighborhoods with high PM2.5 and segregation (n = 232,708, 29,959 with dementia; aHR = 2.28, 95% CI: 2.21–2.36). Within these neighborhoods, older adults in predominantly minority neighborhoods (aHR = 2.85, 95% CI: 2.75–2.95) had a significantly higher risk of dementia compared to those in neighborhoods with low PM2.5 and segregation. Older adults with ESKD in neighborhoods with high PM2.5 experienced an increased risk of dementia; this risk was particularly pronounced among individuals in high segregation and predominantly minority neighborhoods. Environmental and social injustices likely drive racial and ethnic disparities in dementia for older adults with ESKD, underscoring the need for interventions and policies to mitigate these injustices. 10.13039/100000002 National Institutes of Health .